# Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.

> **NCT03248960** · NA · COMPLETED · sponsor: **Ellume Pty Ltd** · enrollment: 381 (actual)

## Conditions studied

- Influenza

## Interventions

- **DIAGNOSTIC_TEST:** iTreat Flu A+B Test
- **DIAGNOSTIC_TEST:** ellume.lab Flu A+B Test
- **DIAGNOSTIC_TEST:** Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
- **DIAGNOSTIC_TEST:** Viral culture

## Key facts

- **NCT ID:** NCT03248960
- **Lead sponsor:** Ellume Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-27
- **Primary completion:** 2017-12-23
- **Final completion:** 2017-12-23
- **Target enrollment:** 381 (ACTUAL)
- **Last updated:** 2018-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03248960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03248960, "Ellume.Lab Flu A+B Test and iTreat Flu A+B Flu Test Performance Versus Viral Culture and Reverse Transcriptase Polymerase Chain Reaction.". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03248960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*